Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 (Q63811425)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1
clinical trial

    Statements

    STR1VE (English)
    0 references
    Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion (English)
    0 references
    0 references
    0 references
    24 October 2017
    0 references
    30 November 2019
    0 references
    20
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit